Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vedolizumab Induction May Prevent Celiac Enteritis After Gluten Challenge in Established Celiac Patients in Histological Remission

NCT02929316 is registered in ClinicalTrials.gov with AGA Clinical Research Associates, LLC as lead sponsor.

NCT NCT02929316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02929316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vedolizumab Induction May Prevent Celiac Enteritis After Gluten Challenge in Established Celiac Patients in Histological Remission
Lead sponsor
AGA Clinical Research Associates, LLC
Phase
Phase 2
Overall status
Terminated
Start date
June 25, 2018
Completion date
October 5, 2018
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease